Filing Details
- Accession Number:
- 0001283913-10-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-25 13:00:00
- Reporting Period:
- 2010-05-21
- Filing Date:
- 2010-05-25
- Accepted Time:
- 2010-05-25 18:40:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 732485 | Genzyme Corp | GENZ | Biological Products, (No Disgnostic Substances) (2836) | 061047163 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021037 | E Alan Smith | 500 Kendall Street Cambridge MA 02142 | Sr Vp,Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme Common Stock (Genz) | Acquisiton | 2010-05-21 | 2,559 | $0.00 | 33,781 | No | 4 | M | Direct | |
| Genzyme Common Stock (Genz | Disposition | 2010-05-21 | 822 | $48.93 | 32,959 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Genzyme Common Stock (Genz) | Restricted Stock Units | Disposition | 2010-05-21 | 2,559 | $0.00 | 2,559 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,083 | 2010-05-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Genzyme Common Stock (Genz) | 221 | Indirect | By 401k |
Footnotes
- Restricted stock unit shares automatically sold to cover withholding tax obligations.
- Includes 164 shares purchased from the issuer's Employee Stock Purchase Plan in April 2010.
- Each restricted stock unit represents a contingent right to receive one share of Genzyme common stock.
- The restricted stock units vest in 1/3 increments beginning on the one year anniversary of the original date of grant.
Billionaire Hedge Funds
